Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,942.00
(
0.87%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
106.68
(
-1.04%
)
Bitcoin
79,033.32
(
0.45%
)
News Focus
News Focus
Post# of 257484
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

biomaven0

Send PM Follow Ignore
Followers 82
Posts 4778
Boards Moderated 0
Alias Born 02/27/2007

biomaven0

Re: iandy post# 145689

Wednesday, 07/18/2012 1:56:36 PM

Wednesday, July 18, 2012 1:56:36 PM

Post# of 257484
Crizotinib failures, so ALK.

The drug is somewhat less potent against EGFR mutations than it is against ALK, so at what level they reach a DLT might be significant.

Peter
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today